DNMT3B and neoplasm: In vivo studies indicate that resveratrol (25 mg/kg/day in a rodent model of estrogen-dependent mammary carcinoma) decreased DNMT3B expression in tumor tissues versus normal mammary tissue; however, no effect was observed on DNMT1 expression [150].